ESC Premium Access

Oral anticoagulants : news from large trials and registries

Event: ESC Congress 2018
Topic: Anticoagulants
Session type: Moderated Posters
Date: 28 August 2018
Time: 15:50 - 16:40

Congress Session

6 presentations in this session

Real-world clinical data of atrial fibrillation patients treated with direct oral anticoagulants in combination with or without antiplatelet therapy

Speaker: Doctor R. Amiya (Osaka, JP)

Characterization of major and clinically relevant non-major bleeding in the APEX trial

Speaker: Miss M. Yee (Boston, US)

Increased major bleeding risk with use of topical miconazole agents among users of oral anticoagulation: A population-level safety study

Speaker: Doctor M. Lamberts (Copenhagen, DK)

Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry

Speaker: Doctor M. Proietti (Milan, IT)

Comparison of P2Y12 inhibitors in atrial fibrillation patients treated by dual-antiplatelet therapy without oral anticoagulant after acute myocardial infarction with percutaneous coronary intervention

Speaker: Professor H. Jeong (Gwangju, KR)

Oral anticoagulants in patients with atrial fibrillation and non-mechanical heart valve disease

Speaker: Mr J. Strange (Copenhagen, DK)

6 speakers from this session

Doctor Ryohei Amiya

Osaka University, Osaka (Japan)
0 follower

Miss Megan Yee

, Boston (United States of America)
0 follower

Doctor Morten Lamberts

Herlev and Gentofte Hospital, Copenhagen (Denmark)
0 follower

Doctor Marco Proietti

University of Milan, Milan (Italy)
6 presentations
0 follower

Professor Hyung Ki Jeong

Chonnam National University Hospital, Gwangju (Korea (Republic of))
0 follower

Mr Jarl Emanuel Strange

Herlev and Gentofte University Hospital, Copenhagen (Denmark)
0 follower

This platform is supported by

logo Novo Nordisk